Evenity (Romosozumab-aqqg) for Osteoporosis

Overview
Evenity is a prescription medication approved by the Food and Drug Administration (FDA) to treat osteoporosis in women after menopause who are at high risk of bone fracture, or who cannot use another osteoporosis medicine. Evenity may be referred to by its drug name, Romosozumab-aqqg.

Evenity is a biologic drug - a genetically engineered antibody, or protein used by the immune system to identify and neutralize substances. Evenity is also a sclerostin inhibitor. Sclerostin is a protein that limits bone formation. Evenity is believed to work by interfering with the action of sclerostin, thereby increasing bone formation and decreasing bone resorption.

How do I take it?
Evenity is administered by subcutaneous injection in a healthcare setting. Evenity is administered once a month for 12 months only.

Calcium and vitamin D supplements must be taken daily while on Evenity.

Side effects
The FDA-approved label for Evenity lists common side effects including joint pain and headaches.

Rare but serious side effects listed for Evenity include increased risk for heart attack, stroke, or death from a cardiovascular (heart or blood vessel) problem. Rarely, Evenity can also cause hypersensitivity reactions, atypical femoral (upper leg) fractures, and osteonecrosis (bone death) of the jaw.

For more details about this treatment, visit:
Evenity – Amgen
https://www.evenity.com/